{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:42:15Z","timestamp":1784202135833,"version":"3.55.0"},"reference-count":40,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T00:00:00Z","timestamp":1435104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"\u00a0Firat University Scientific Research Unit (authors\u2019 owner institution)"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Exper Ophthalmology"],"published-print":{"date-parts":[[2015,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The aim of this study was to compare the effects of lapatinib and trastuzumab on vascular endothelial growth factor on experimental corneal neovascularization.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 35 <jats:styled-content style=\"fixed-case\">W<\/jats:styled-content>istar albino rats were randomly divided into five groups, each containing seven animals. Corneas of rats in the control group were not cauterized and did not receive any treatment. A silver nitrate pencil was applied on the right corneas of rats in the non\u2010control groups to induce corneal neovascularization. Rats in the sham, lapatinib, trastuzumab and lapatinib\u2009+\u2009trastuzumab groups were administered systemic saline, 50\u2009mg\/kg lapatinib once a day orally by gavage, 4\u2009mg\/kg trastuzumab once a day intraperitoneally, or 50\u2009mg\/kg lapatinib once a day orally by gavage together with 4\u2009mg\/kg trastuzumab once a day intraperitoneally, respectively, for 7 days. Rats were sacrificed on the eighth day, and corneas were excised using a 4\u2010mm punch trephine. Vascular endothelial growth factor immunostaining in the corneal epithelial and stromal layers was evaluated. Staining intensities were determined semi\u2010quantitatively, and corneal vascular endothelial growth factor levels were measured by enzyme\u2010linked immunosorbent assay.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean immunostaining intensities of epithelial and stromal vascular endothelial growth factor in the control group were significantly lesser than those in the sham group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). The mean immunostaining intensities of epithelial and stromal vascular endothelial growth factor and vascular endothelial growth factor enzyme\u2010linked immunosorbent assay levels of corneas in all treatment groups (lapatinib, trastuzumab and lapatinib\u2009+\u2009trastuzumab groups) were lesser than those in the sham group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05); however, it was similar to those in the control group (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>It is suggested that systemically administered lapatinib is more effective than systemically administered trastuzumab in preventing corneal neovascularization.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ceo.12500","type":"journal-article","created":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T08:18:39Z","timestamp":1422865119000},"page":"449-457","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effects of lapatinib and trastuzumab on vascular endothelial growth factor in experimental corneal neovascularization"],"prefix":"10.1111","volume":"43","author":[{"given":"Mehmet K","family":"Kaya","sequence":"first","affiliation":[{"name":"Ophthalmology Clinic Avrupa G\u00f6z Hastanesi  Elazig Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer","family":"Demir","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology School of Medicine F\u0131rat University  Elazig Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Bulut","sequence":"additional","affiliation":[{"name":"School of Veterinary Science F\u0131rat University  Elazig Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nusret","family":"Akpolat","sequence":"additional","affiliation":[{"name":"Department of Pathology School of Medicine \u0130n\u00f6n\u00fc University  Malatya Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Turgut","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology School of Medicine F\u0131rat University  Elazig Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,6,24]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/00055735-200108000-00002"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-199811000-00008"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2006.00659.x"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199412013312203"},{"key":"e_1_2_5_6_1","first-page":"18","article-title":"Requirement for vascular endothelial growth factor in wound and inflammation related corneal neovascularization","volume":"39","author":"Amano S","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_5_7_1","first-page":"961","article-title":"Vascular endothelial growth factor (rhVEGF165) stimulates direct angiogenesis in the rabbit cornea","volume":"8","author":"Phillips GD","year":"1994","journal-title":"In Vivo"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2004.00312.x"},{"key":"e_1_2_5_9_1","first-page":"1112","article-title":"Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea","volume":"40","author":"Edelman JL","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63267-1"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/19.7.1525"},{"key":"e_1_2_5_12_1","first-page":"1625","article-title":"A model of angiogenesis in the mouse cornea","volume":"37","author":"Kenyon BM","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_5_13_1","first-page":"18","article-title":"Requirement for vascular endothelial growth factor in wound\u2010and inflammation\u2010related corneal neovascularization","volume":"39","author":"Amano S","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e318201405a"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2012.01.007"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(98)00035-6"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.2174\/187221309789257450"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl475"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi905"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64253-8"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/416279b"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209685"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2008.09.022"},{"key":"e_1_2_5_24_1","first-page":"665","article-title":"A review of lapatinib ditosylate in the treatment of refractory or advanced breast cancer","volume":"3","author":"Nelson MH","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2013.00250"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn436"},{"key":"e_1_2_5_27_1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3109\/02713688508999984","article-title":"Drug effects on the neovascularization response to silver nitrate cauterization of the rat cornea","volume":"4","author":"Mahoney JM","year":"1985","journal-title":"Curr Eye Res"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2006.107912"},{"key":"e_1_2_5_29_1","first-page":"2514","article-title":"Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas","volume":"41","author":"Philipp W","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_5_30_1","first-page":"2115","article-title":"Constitutive expression of VEGF, VEGFR\u20101, and VEGFR\u20102 in normal eyes","volume":"40","author":"Kim I","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200007000-00025"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1609"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc1243"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2008.08.008"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1075-122x.2005.21463.x"},{"key":"e_1_2_5_36_1","first-page":"279","article-title":"Lapatinib: new opportunities for management of breast cancer","volume":"2","author":"Liao J","year":"2010","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"e_1_2_5_37_1","first-page":"35","article-title":"Role of lapatinib alone or in combination in the treatment of HER2\u2010positive breast cancer","volume":"4","author":"Hurvitz SA","year":"2012","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2011.03.012"},{"key":"e_1_2_5_39_1","first-page":"3859","article-title":"Tyrphostin AG1478 preferentially inhibits human glioma cells expressing truncated rather than wild\u2010type epidermal growth factor receptors","volume":"56","author":"Han Y","year":"1996","journal-title":"Cancer Res"},{"key":"e_1_2_5_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa064320"},{"key":"e_1_2_5_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyq084"}],"container-title":["Clinical &amp; Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fceo.12500","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ceo.12500","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T20:07:24Z","timestamp":1695499644000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ceo.12500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,24]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.1111\/ceo.12500"],"URL":"https:\/\/doi.org\/10.1111\/ceo.12500","archive":["Portico"],"relation":{},"ISSN":["1442-6404","1442-9071"],"issn-type":[{"value":"1442-6404","type":"print"},{"value":"1442-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,24]]},"assertion":[{"value":"2014-05-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-11-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-06-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}